Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial
<$O_ST_ABS>Background<$C_ST_ABS>The discussion on the role of adjuvant chemotherapy for rectal cancer patients treated according to current guidelines is still ongoing. A multicentre, randomized phase III trial, PROCTOR-SCRIPT, was conducted to compare adjuvant chemotherapy with observation for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision (TME). <$O_ST_ABS>Patients and methods<$C_ST_ABS>The PROCTOR-SCRIPT trial recruited patients from 52 hospitals. Patients with histologically proven stage II or III rectal adenocarci... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | TEXT |
Erscheinungsdatum: | 2015 |
Verlag/Hrsg.: |
Oxford University Press
|
Schlagwörter: | Original article |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28582923 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://annonc.oxfordjournals.org/cgi/content/short/mdu560v2 |